Contract GE22
Amerisourcebergen Drug Corp · Department Of Defense · June 26, 2000
Amerisourcebergen Drug Corp was awarded a federal contract by Department Of Defense (Defense Logistics Agency) on June 26, 2000 for $1.81 million of work in medicinal and botanical manufacturing. Performance is in Chesterbrook, PA. This is a task or delivery order issued under parent IDIQ SPE2DX15D3103. The contract has been modified 94 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 29, 2017.
Contract details
- PIID
- GE22
- Parent IDIQ
- SPE2DX15D3103
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325411 · Medicinal And Botanical Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Chesterbrook, PA
- First action
- June 26, 2000
- Latest action
- September 29, 2017
Description
4539523779!TRICARE WEST
Modification timeline
-
September 29, 2017Base award$781
-
September 6, 2017Base award4539237987!PRIME VENDOR PHARM BRANCH-PHILADELPHIA$244
-
August 31, 2017Base award4539183210!TRICARE WEST$3.4K
-
July 26, 2017Base award4538764720!TRICARE WEST$3.0K
-
June 6, 2017Base award4538247782!PRIME VENDOR PHARM BRANCH-PHILADELPHIA$2.5K
-
May 12, 2017Base award4538016060!TRBO REGION 7/8$451
-
April 13, 2017Base award4537693332!PRIME VENDOR PHARM BRANCH-PHILADELPHIA$5.0K
-
March 20, 2017Base award4537387701!TRBO REGION 7/8$3.3K
-
January 30, 2017Base award4536842348!TRBO REGION 7/8$714
-
January 30, 2017Base award4536847375!TRBO REGION 7/8$82
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $232 |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $13.1K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $1.9K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $220.9K |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $135 |
| Amerisourcebergen Drug Corp | Department Of Defense | January 1, 2026 | $39.8K |
Top contractors in NAICS 325411
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 372,977 | $24.02B |
| 2 | Amerisourcebergen Drug Corp | 1,414,856 | $18.32B |
| 3 | Glaxosmithkline, Llc | 44 | $5.42B |
| 4 | Merck Sharp & Dohme Llc | 3 | $1.50B |
| 5 | Novartis Vaccines And Diagnostics, Inc. | 132 | $1.07B |
| 6 | Sanofi Vaccines Us Inc. | 57 | $650.53M |
| 7 | Cardinal Health, Inc. | 42,916 | $603.29M |
| 8 | Dms Pharmaceutical Group Inc | 113,930 | $547.06M |
| 9 | Cardinal Health 100, Inc | 7,655 | $486.24M |
| 10 | Glaxosmithkline Holdings (Americas) Inc. | 72 | $280.01M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract GE22?
Contract GE22 is a federal contract awarded to Amerisourcebergen Drug Corp by Department Of Defense on June 26, 2000 for $1.81 million of work classified under MEDICINAL AND BOTANICAL MANUFACTURING. It has been modified 94 times since the base award.
Who won contract GE22?
Amerisourcebergen Drug Corp won contract GE22 from Department Of Defense.
How much is contract GE22 worth?
Contract GE22 has obligated $1.81 million to date.